Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 7, 2013, Pages 4982-4990

  Butler, Michelle R ^a   Prospero Ponce, Claudia M ^b   Etan Weinstock, Y ^c   Orengo Nania, Silvia ^a   Chevez Barrios, Patricia ^a,b   Frankfort, Benjamin J ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Filtration surgery; Glaucoma; Mitomycin C; Rabbit; Silver nanoparticle

Indexed keywords

MITOMYCIN; SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EYE EDEMA; FILTERING OPERATION; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; ISCHEMIA; LYMPHOCYTE; MYOFIBROBLAST; NANOFILTRATION; NONHUMAN; OCULAR FIBROSIS; PRIORITY JOURNAL; RABBIT;

FILTRATION SURGERY; GLAUCOMA; MITOMYCIN C; RABBIT; SILVER NANOPARTICLE;

ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTICS, ANTINEOPLASTIC; BLISTER; DISEASE MODELS, ANIMAL; FILTERING SURGERY; GLAUCOMA; INTRAOCULAR PRESSURE; METAL NANOPARTICLES; MITOMYCIN; RABBITS; SILVER;

EID: 84880724225     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12047     Document Type: Article

References (46)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative NormalTension Glaucoma Study Group. Am J Ophthalmol. 1998;126: 498-505.
3. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720, discussion 829-730.
4. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
5. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101:795-798.
6. Skuta GL, Parrish RK II. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149-170.
7. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;4: CD002897.
8. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314-346.
9. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1993;115:82-92.
10. Bergstrom TJ, Wilkinson WS, Skuta GL, Watnick RL, Elner VM. The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol. 1991;109: 1725-1730.
11. Lu DW, Chang CJ, Chiang CH, Yeh MK, Chou PI. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. J Ocul Pharmacol Ther. 2000;16: 529-538.
12. Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK. Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol. 1996;234:364-368.
13. Wilson MR, Lee DA, Baker RS, Goodwin LT, Wooten F. The effects of topical mitomycin on glaucoma filtration surgery in rabbits. J Ocul Pharmacol. 1991;7:1-8.
14. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120: 297-300.
15. Khaw PT, Chang L, Wong TT, Mead A, Daniels JT, Cordeiro MF. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001;12:143-148.
16. Akman A, Bilezikci B, Kucukerdonmez C, Demirhan B, Aydin P. Suramin modulates wound healing of rabbit conjunctiva after trabeculectomy: comparison with mitomycin C. Curr Eye Res. 2003;26:37-43.
17. Akyol N, Akpolat N. Effects of intraoperative oxidated regenerated cellulose on wound healing reaction after glaucoma filtration surgery: a comparative study with Interceed and Surgicel. Indian J Ophthalmol. 2008;56:109-114.
18. Li Z, Van Bergen T, Van, de Veire S et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009; 50:5217-5225.
19. Memarzadeh F, Varma R, Lin LT, et al. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 2009;50: 3233-3237.
20. Mietz H, Chevez-Barrios P, Feldman RM, Lieberman MW. Suramin inhibits wound healing following filtering procedures for glaucoma. Br J Ophthalmol. 1998;82:816-820.
21. Nuzzi R, Cerruti A, Finazzo C. Cyclosporine C: a study of wound-healing modulation after trabeculectomy in rabbit. Acta Ophthalmol Scand Suppl. 1998;227:48-49.
22. Sen E, Balikoglu-Yilmaz M, Bozdag-Pehlivan S, et al. Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model. J Ocul Pharmacol Ther. 2010; 26:399-406.
23. Sha Q, Jiao GY, Cui HB, et al. Inhibitory effect of biopolymer materials on scar formation following trabeculectomy. Int J Ophthalmol. 2011;4:380-383.
24. Shouman AA, Helal A, Marzouk MA, Zaki EM. Methylcellulose, a healing inhibitor factor in an animal model of trabeculectomy. Invest Ophthalmol Vis Sci. 2006;47:2515-2519.
25. Spitzer MS, Sat M, Schramm C, et al. Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a releasesystem for tranilast after trabeculectomy in a rabbit model-a pilot study. Curr Eye Res. 2012;37:463-470.
26. Takeuchi K, Nakazawa M, Ebina Y, et al. Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery. Exp Eye Res. 2010;91:567-577.
27. Takeuchi K, Nakazawa M, Yamazaki H, et al. Solid hyaluronic acid film and the prevention of postoperative fibrous scar formation in experimental animal eyes. Arch Ophthalmol. 2009;127:460-464.
28. Tsurumaru N, Arai M, Teruya K, Sueda J, Yamakawa R. Seprafilm as a new antifibrotic agent following trabeculectomy in rabbit eyes. Jpn J Ophthalmol. 2009;53:164-170.
29. Xu XD, Liang L, Chen CS, et al. Peptide hydrogel as an intraocular drug delivery system for inhibition of postoperative scarring formation. ACS Appl Mater Interfaces. 2010;2: 2663-2671.
30. Yan ZC, Bai YJ, Tian Z, et al. Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery. Mol Vis. 2011;17:2495-2506.
31. Zhong H, Sun G, Lin X, Wu K, Yu M. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci. 2011;52:3136-3142.
32. Lara HH, Garza-Trevino EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology. 2011;9:30.
33. You C, Han C, Wang X, et al. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep. 2012;39:9193-9201.
34. Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71:7589-7593.
35. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology. 2007;18:225103-225112.
36. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2006;1:441-449.
37. Tian J, Wong KK, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem. 2007;2:129136.
38. Liu X, Lee PY, Ho CM, et al. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem. 2010;5:468-475.
39. Wong KK, Cheung SO, Huang L, et al. Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem. 2009;4:1129-1135.
40. Lee KJ, Browning LM, Nallathamby PD, Desai T, Cherukuri PK, Xu XH. In vivo quantitative study of sized-dependent transport and toxicity of single silver nanoparticles using zebrafish embryos. Chem Res Toxicol. 2012;25:1029-1046.
41. Ordzhonikidze CG, Ramaiyya LK, Egorova EM, Rubanovich AV. Genotoxic effects of silver nanoparticles on mice in vivo. Acta Naturae. 2009;1:99-101.
42. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19:975-983.
43. Kim JS, Song KS, Sung JH, et al. Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles. Nanotoxicology. 2013;7:953-960.
44. Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci. 2011;73:1417-1423.
45. Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 1997;38:1639-1646.
46. Wells AP, Crowston JG, Marks J, et al. A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma. 2004;13:454-460.